Sign In
Buy ABMD
$381.02
+0 (+0%)
At Close: Mar 20, 2023
After 150 days of the COVID-19 pandemic, here are the best- and worst-performing stocks
11:06am, Monday, 10'th Aug 2020
The tech sector is still in the lead, but consumer-discretionary group trails only slightly.
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Abiomed (ABMD –
ABIOMED (ABMD) Earnings and Revenues Beat Estimates in Q1
01:26pm, Thursday, 06'th Aug 2020
ABIOMED's (ABMD) flagship Impella saw decline in revenues internationally and within the United States, in Q1.
Abiomed (ABMD) Tops Q1 Earnings and Revenue Estimates
12:25pm, Thursday, 06'th Aug 2020
Abiomed (ABMD) delivered earnings and revenue surprises of 176.19% and 19.26%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Abiomed Announces Q1 FY 2021 Revenue of $165 Million and 21% Operating Margin | | IT Business Net
12:02pm, Thursday, 06'th Aug 2020
June Revenue Up 4% Versus Prior Year DANVERS, Mass.--(BUSINESS WIRE)--Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies today reported first quarter fiscal 20
Abiomed Announces Q1 FY 2021 Revenue of $165 Million and 21% Operating Margin
11:00am, Thursday, 06'th Aug 2020
Abiomed announces Q1 FY 2021 revenue of $165 million and 21% operating margin.
La Food and Drug Administration (FDA) américaine vient d'octroyer une autorisation d'utilisation d'urgence (EUA) aux pompes cardiaques Impella pour of
La Administración de Alimentos y Medicamentos de Estados Unidos (Food and Drug Administration, FDA) ha emitido una autorización de uso de emergencia (
Stocks close higher as stimulus talks continue, with Nasdaq notching new high
08:10pm, Tuesday, 04'th Aug 2020
Stocks closed modestly higher after a choppy trading session Tuesday, with investors keeping one eye on stimulus talks in Washington and another on mixed...
Abiomed’s Impella Scores Emergency FDA Nod For Covid-19 Patients
04:39pm, Tuesday, 04'th Aug 2020
Abiomed (ABMD) has announced that the US Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for left-sided Impella heart
Coronavirus News: FDA Gives Emergency-Use Authorization To Heart Pump For COVID-19 Patients
03:22pm, Tuesday, 04'th Aug 2020
The Impella heart pump from Abiomed treats edema or myocarditis, which can occur in COVID-19 patients.
Coronavirus update: U.S. case tally at 4.72 million and New Jersey, Massachusetts and Connecticut see infections climb again
03:18pm, Tuesday, 04'th Aug 2020
The U.S. case tally for the coronavirus illness COVID-19 rose by fewer than 50,000 on Monday for a second straight day, data aggregated by Johns Hopkins...
ABIOMED (ABMD) to Report Q1 Earnings: What's in the Offing?
12:50pm, Tuesday, 04'th Aug 2020
The commercial rollout of ABIOMED's (ABMD) Impella 5.5 is expected to have progressed steadily through the fiscal first quarter.
Abiomed’s Impella Scores Emergency FDA Nod For Covid-19 Patients
12:39pm, Tuesday, 04'th Aug 2020
Abiomed (ABMD) has announced that the US Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for left-sided Impella heart pumps to provide left ventricular unloading a
